Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chimerix Inc (CMRX)

Chimerix Inc (CMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 77,888
  • Shares Outstanding, K 89,630
  • Annual Sales, $ 320 K
  • Annual Income, $ -82,100 K
  • 60-Month Beta 1.20
  • Price/Sales 242.33
  • Price/Cash Flow N/A
  • Price/Book 0.45
Trade CMRX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.92
  • Most Recent Earnings $-0.25 on 05/01/24
  • Next Earnings Date 08/01/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 82.26% ( +27.78%)
  • Historical Volatility 31.35%
  • IV Percentile 77%
  • IV Rank 22.95%
  • IV High 354.84% on 02/23/24
  • IV Low 1.08% on 09/27/23
  • Put/Call Vol Ratio 0.50
  • Today's Volume 3
  • Volume Avg (30-Day) 107
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 8,163
  • Open Int (30-Day) 7,423

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.23
  • Number of Estimates 5
  • High Estimate -0.21
  • Low Estimate -0.27
  • Prior Year -0.21
  • Growth Rate Est. (year over year) -9.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8600 +0.29%
on 07/02/24
0.9800 -11.99%
on 06/03/24
-0.1043 (-10.79%)
since 05/31/24
3-Month
0.8600 +0.29%
on 07/02/24
1.0700 -19.39%
on 04/04/24
-0.1475 (-14.60%)
since 04/02/24
52-Week
0.8600 +0.29%
on 07/02/24
1.3000 -33.65%
on 03/08/24
-0.3475 (-28.72%)
since 06/30/23

Most Recent Stories

More News
Chimerix: Q1 Earnings Snapshot

Chimerix: Q1 Earnings Snapshot

CMRX : 0.8625 (-0.75%)
Chimerix: Q4 Earnings Snapshot

Chimerix: Q4 Earnings Snapshot

CMRX : 0.8625 (-0.75%)
Chimerix: Q3 Earnings Snapshot

Chimerix: Q3 Earnings Snapshot

CMRX : 0.8625 (-0.75%)
Chimerix: Q2 Earnings Snapshot

Chimerix: Q2 Earnings Snapshot

CMRX : 0.8625 (-0.75%)
Chimerix: Q1 Earnings Snapshot

Chimerix: Q1 Earnings Snapshot

CMRX : 0.8625 (-0.75%)
Chimerix: Q4 Earnings Snapshot

Chimerix: Q4 Earnings Snapshot

CMRX : 0.8625 (-0.75%)
Rubric Capital Management Sends Letter to Chimerix Board of Directors

Rubric Capital Management LP (“Rubric”), an investment adviser whose managed funds and accounts collectively own approximately 8.5% of the common stock of Chimerix, Inc. (“Chimerix” or the “Company”)...

CMRX : 0.8625 (-0.75%)
Chimerix: Q3 Earnings Snapshot

Chimerix: Q3 Earnings Snapshot

CMRX : 0.8625 (-0.75%)
Demand for Comprehensive Cleaning Services Grow Post-Pandemic

/PRNewswire/ -- Due to the growing implementation of AI and automation in household equipment, the domestic robot market reached a high growth rate in recent...

EJH : 1.0700 (+4.90%)
IRBT : 8.73 (-1.36%)
CMRX : 0.8625 (-0.75%)
WM : 209.47 (+0.05%)
PATH : 12.96 (+0.62%)
Chimerix (CMRX) Q2 2022 Earnings Call Transcript

CMRX earnings call for the period ending June 30, 2022.

CMRX : 0.8625 (-0.75%)

Business Summary

Chimerix is a biopharmaceutical company which develop medicines for lives of patients facing deadly diseases. The Company's most advanced clinical-stage development program ONC201, is in development for H3 K27M-mutant glioma. Chimerix is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 0.9108
2nd Resistance Point 0.9002
1st Resistance Point 0.8813
Last Price 0.8625
1st Support Level 0.8518
2nd Support Level 0.8412
3rd Support Level 0.8223

See More

52-Week High 1.3000
Fibonacci 61.8% 1.1319
Fibonacci 50% 1.0800
Fibonacci 38.2% 1.0281
Last Price 0.8625
52-Week Low 0.8600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar